• Boston University

Register for New Account

Register

Provide your credentials to log in
Remember Me Login

Forgot your password?

For core clinical content designed to help you safely and effectively manage patients with chronic pain, when appropriate, with opioid analgesics, please visit our sister site, SCOPE of Pain.

 

  1. Optimizing Office Systems
  2. Office Systems Safe and Competent Opioid Prescribing: Optimizing Office Systems Program CME Post-Test Evaluation
  1. Massachusetts Laws
  2. Educational Program Making Sense of Massachusetts Opioid Prescribing Laws and State and National Guidelines Program CME Post-Test Evaluation
  1. Dental Pain
  2. Educational Program Safe Opioid Prescribing for
    Acute Dental Pain
    Program CME Post-Test Evaluation
  1. Prescribe to Prevent
  2. Educational Program Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists Information Program CME Post-Test Evaluation
  1. Military Modules
  2. Module 1 Military SCOPE of Pain: Safe and Competent Opioid Prescribing For Providers Working with Veterans and Military Service Personnel Information Video CME Post-Test Evaluation
  3. Module 2 Military SCOPE of Pain: Safe and Competent Opioid Prescribing For Providers Working with Veterans and Military Service Personnel Information Video CME Post-Test Evaluation
  1. Video Modules
  2. Module 1 Case Studies In Practice: Applying Principles
    of Safe Opioid Prescribing
    Information Introduction Cases Case I Case II Case III Certification CME Post-Test Evaluation
  3. Module 2 Complex Convrs. High Dose Opioids
    & Illicit Drug Use
    Information Introduction Cases Case I-A Case I-B Case II Certification CME Post-Test Evaluation
  4. Module 3 Using the PDMP PMP Questionable Activity Information Introduction Cases Case I Case II Certification CME Post-Test Evaluation

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1.75 hours of risk management study.

This program meets the criteria of the Massachusetts Board of Registration in Medicine for 1.75 hours of opioid education.

In order to receive credit, participants must view the content of each module and complete the post-test and evaluation for each. Participants who receive a grade of 70% or greater on the post-tests will receive credit. BOTH MODULES MUST BE COMPLETED BEFORE CREDIT WILL BE AWARDED.

 

Target Audience

Physicians, nurse practitioners, physician assistants, and pharmacists.

 

Educational Objectives

MODULE 1

At the conclusion of this activity, participants will be able to:

  • Discuss the breadth and quality of evidence for the use of opioids for chronic pain, including current gaps in knowledge.
  • Describe current treatment paradigms for treating patients with chronic pain.

 

MODULE 2

At the conclusion of this activity, participants will be able to:

  • Describe the use of universal precautions when treating patients with chronic pain.
  • Apply appropriate communications strategies when initiating, managing, and, if necessary, terminating opioids for patients with chronic pain.

 

Date of Original Release: January 6, 2014
Date of Most Recent Review: January 6, 2017
Date of Expiration:  January 5, 2018

 

For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.

To view Boston University’s Privacy Policy, please see http://www.bumc.bu.edu/cme/policies/.

 

Disclosure Policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

 

Faculty

Daniel P. Alford, MD, MPH, FACP (Course Director)
Professor of Medicine
Boston University School of Medicine
Boston Medical Center
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that he does not discuss unlabeled/investigational uses of a commercial product.
dan.alford@bmc.org

 

Karen H. Seal, MD, MPH
San Francisco VA Medical Center and the University of California, San Francisco
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.

 

Emily Sachs, PhD
San Francisco VA Medical Center and the University of California, San Francisco
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.

 

Tracy Lin, PharmD
San Francisco VA Medical Center and the University of California, San Francisco
Faculty member has nothing to disclose with regards to commercial support. Faculty member indicates that she does not plan to discuss unlabeled/investigational uses of a commercial product.

 

Ilana Hardesty, Program Operations Manager, Boston University School of Medicine CME Office, has nothing to disclose with regards to commercial support.

 

 

Disclaimer

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

 

Funding

This web-based activity is supported by the Substance Abuse and Mental Health Services Administration of the U.S. Department of Health and Human Services.